PARDES BIOSCIENCES INC's ticker is and the CUSIP is 69945Q105. A total of 1 filers reported holding PARDES BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $215,969 | -63.6% | 119,320 | -73.4% | 0.00% | – |
Q1 2023 | $592,986 | -60.6% | 449,232 | -49.6% | 0.00% | – |
Q4 2022 | $1,506,530 | +93.1% | 891,438 | +111.6% | 0.00% | – |
Q3 2022 | $780,000 | -24.4% | 421,358 | +25.3% | 0.00% | – |
Q2 2022 | $1,032,000 | +73.4% | 336,308 | +308.0% | 0.00% | – |
Q1 2022 | $595,000 | – | 82,420 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Opportunity Management V, LLC | 5,227,307 | $37,741,000 | 52.85% |
Foresite Capital Management V, LLC | 9,400,515 | $67,872,000 | 27.72% |
Lynx1 Capital Management LP | 1,642,834 | $11,861,000 | 11.01% |
Frazier Life Sciences Management, L.P. | 2,081,007 | $15,025,000 | 1.28% |
RA Capital Management | 6,175,038 | $44,584,000 | 0.97% |
Arena Capital Advisors, LLC- CA | 851,281 | $6,146,000 | 0.93% |
DAFNA Capital Management LLC | 421,157 | $3,041,000 | 0.79% |
Sio Capital Management, LLC | 315,564 | $2,278,000 | 0.75% |
TCG Crossover Management, LLC | 229,100 | $1,654,000 | 0.66% |
Altium Capital Management LP | 253,000 | $1,827,000 | 0.61% |